Community-acquired pneumonia of mixed etiology: Prevalence, clinical characteristics, and outcome

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 24, Issue 6, 2005, Pages 377-383

  Gutierrez F ^a   Masia M ^a   Rodriguez J C ^b   Mirete, C ^a   Soldan B ^a   Padilla, S ^a   Hernandez I ^c   Royo, G ^b   Martin Hidalgo, A ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^c MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM; COMMUNITY ACQUIRED PNEUMONIA; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; HUMAN; OUTPATIENT; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; BACTERIA; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PREVALENCE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 21744452877     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-005-1346-2     Document Type: Article

References (41)

1. Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM (2000) Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 31:347-382
2. Mandell LA, Bartlett JG, Dowel SF, File TM Jr, Musher DM, Whitney C (2003) Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 37:1405-1433
3. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martínez F, Marrie TJ, Plouffe JF, Ramírez J, Sarosi GA, Torres A, Wilson R, Yu VL (2001) American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163:1730-1754
4. Niederman MS, McCombs J, Unger A, Kumar A, Popovian R (1998) The cost of treating community-acquired pneumonia. Clin Ther 20:820-836
5. Heiskanen-Kosma T, Korppi M, Jokinen C, Kurki S, Heiskanen L, Juvonen H, Kallinen S, Sten M, Tarkiainen A, Ronnberg PR, Kleemola M, Makela PH, Leinonen M (1998) Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J 17:986-991
6. Kauppinen MT, Herva E, Kujala P, Leinonen M, Saikku P, Syrjala H (1995) The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. J Infect Dis 172:1330-1335
7. Lieberman D, Schlaeffer F, Boldur I, Leberman D, Horowitz S, Friedman MG, Leiononen M, Horovitz O, Manor E, Porath (1996) Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one-year prospective study of 346 consecutive patients. Thorax 51:179-184
8. Bates JH, Campbell GD, Barron AL, McCracken GA, Morgan PN, Moses EB, Davis CM (1992) Microbial etiology of acute pneumonia in hospitalized patients. Chest 101:1005-1012
9. Burman LA, Trollfors B, Andersson B, Henrichsen J, Juto P, Kallings I, Lagergard T, Mollby R, Norrby R (1991) Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens. J Infect Dis 163:1087-1093
10. Gleason PP (2002) The emerging role of atypical pathogens in community-acquired pneumonia. Pharmacotherapy 22 (1 Pt 2):2-11
11. Lim WS, Macfarlane JT, Boswell TC, Harrison TG, Rose D, Leinonen M, Saikku P (2001) Study of community-acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 56:296-301
12. Plouffe JF (2000) Importance of atypical pathogens of community-acquired pneumonia. Clin Infect Dis 31 (Suppl 2):35-39
13. Mufson MA, Stanek RJ (1999) Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study, 1978-1997. Am J Med 107 (Suppl 1A):34-43
14. Martínez JA, Horcajada JP, Almela M, Marco F, Soriano A, García E, Marco MA, Torres A, Mensa J (2003) Addition of a macrolide to a β-lactam based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 36:396-398
15. Waterer GW, Somes GW, Wunderink RG (2001) Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 161:1837-1842
16. Berntsson E, Blomberg J, Lagergard T, Trollfors B (1985) Etiology of community-acquired pneumonia in patients requiring hospitalization. Eur J Clin Microbiol 4:268-272
17. Berntsson E, Lagergard T, Strannegard O, Trollfors B (1986) Etiology of community-acquired pneumonia in out-patients. Eur J Clin Microbiol 5:446-447
18. Blanquer J, Blanquer R, Borras R, Nauffal D, Morales P, Menendez R, Subias I, Herrero L, Redon J, Pascual J (1991) Aetiology of community-acquired pneumonia in Valencia, Spain. A multicentre prospective study. Thorax 46:508-511
19. Bochud PY, Moser F, Erard P, Verdon F, Studer JP, Villard G, Cosendai A, Cotting M, Heim F, Tissot J, Strub Y, Pazeller M, Saghafi L, Wenger A, Germann D, Matter L, Bille J, Pfister L, Francioli P (2001) Community-acquired pneumonia. A prospective outpatient study. Medicine (Baltimore) 80:75-87
20. Marrie TJ, Peeling RW, Fine MJ, Singer DE, Coley CM, Kapoor WN (1996) Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am J Med 101:508-515
21. Marston BJ, Plouffe JF, File TM Jr, Hackman BA, Salstrom SJ, Lipman HB, Kolczak MS, Breiman RF (1997) Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med 157:1709-1718
22. Thom DH, Grayston JT, Campbell LA, Kuo CC, Diwan VK, Wang SE (1994) Respiratory infection with Chlamydia pneumoniae in middle-aged and older adult outpatients. Eur J Clin Microbiol Infect Dis 13:785-792
23. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336:243-250
24. Almirall J, Bolíbar I, Vidal J, Sauca G, Coll P, Niklasson B, Bartolomé M, Balanzó X (2000) Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J 15:757-763
25. Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, Kapoor W, Grayston JT, Wang SP, Kohler R, Muder RR, Yee YC, Rihs JD, Vickers RM (1990) New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine 69:307-316
26. Almirall J, Morato I, Riera F, Verdaguer A, Priu R, Coll P, Vidal J, Murguí L, Valls F, Catalan F (1993) Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection. A prospective multicentre study. Eur Respir J 6:14-18
27. Marrie TJ, Durant H, Yates L (1989) Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 11:586-599
28. McConnell CT Jr, Plouffe JF, File TM, Mueller CF, Wong KH, Skelton SK, Marston BJ, Breiman RF, for the CBPIS Study Group (1994) Radiographic appearances of Chlamydia pneumoniae (TWAR strain) respiratory infections. Radiology 192:819-824
29. Marrie TJ, Peeling RW, Reid T, De Carolis E, and the Canadian Community-Acquired Pneumonia Investigators (2003) Chlamydia species as a cause of community-acquired pneumonia in Canada. Eur Respir J 21:779-784
30. Bakaletz LO (1995) Viral potentiation of bacterial superinfection of the respiratory tract. Trends Microbiol 3:110-114
31. Schwarzmann SW, Adler JL, Sullivan RJ (1971) Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969. Arch Intern Med 127:1037-1041
32. Madhi SA, Klugman KP, and the Vaccine Trialist Group (2004) A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 10:811-813
33. Rosón B, Fernández-Sabé Carratalá J, Verdaguer R, Dorca J, Manresa F, Gudiol F (2004) Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia. Clin Infect Dis 38:222-226
34. Domínguez J, Blanco S, Rodrigo C, Azuara M, Gali N, Mainou A, Esteve A, Castellvi A, Prat C, Matas L, Ausina V (2003) Usefulness of urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal pneumonia in children. J Clin Microbiol 41:2161-2163
35. Faden H, Heimerl M, Varma C, Goodman G, Winkelstein P (2002) Urinary excretion of pneumococcal cell wall polysaccharide in children. Pediatr Infect Dis J 21:791-793
36. Murdoch DR, Laing RT, Cook JM (2003) The NOW S. pneumoniae urinary antigen test positivity rate 6 weeks after pneumonia onset and among patients with COPD. Clin Infect Dis 37:153-154
37. Dudas V, Hopefl A, Jacobs R, Guglielmo BJ (2000) Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals. Ann Pharmacother 34:446-452
38. Gleason PP, Meehan TP, Fine JM, Galusha DH, Fine MJ (1999) Association between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 159:2562-2572
39. Houck PM, MacLehose RF, Niederman MS, Lowery JK (2001) Empiric antibiotic therapy and mortality among Medicare pneumonia inpatients in 10 western states: 1993, 1995, and 1997. Chest 119:1420-1426
40. Stahl JE, Barza M, DesJardin J, Martin R, Eckman MH (1999) Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia. Arch Intern Med 159:2576-2580
41. File TM, Mandell LA (2003) What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia? Clin Infect Dis 36:396-398